News
Neurosoft Bioelectronics wins the final stage of Venture Kick
We are very pleased to announce that Neurosoft Bioelectronics has won the highest stage of Venture Kick and received a final round of funding for a total of 150 000 CHF. The Venture Kick jury has selected our project to receive the final “kick”, supporting us in the...
Neurosoft Bioelectronics is one of the 8 Prix Strategis semi-finalists!
We are proud to announce that Neurosoft Bioelectronics has been selected as one of the 8 semi-finalist startups competing for the Prix Strategis 2021. The Jury has selected our project out of 111 promising applicants. The next step will be a meeting with students from...
Welcome to Karsten Bagger – new Chief Business Officer (CBO)
We are happy to announce that Karsten Bagger has joined Neurosoft Bioelectronics as its Chief Business Officer (CBO).Karsten has a MSc in Finance, he previously worked at UBS as an investment strategist and over the past 6 years, he has mainly headed up medtech...
Venture Leader Nicolas Vachicouras shares his experience in creating Neurosoft Bioelectronics
In April our CEO and co-founder Nicolas Vachicouras was selected to represent Neurosoft Bioelectronics as part of the Swiss National Startup Team for Venture Leaders Life Sciences 2020. In November he will have the opportunity to travel to Boston, a major medical hub,...
Neurosoft Bioelectronics passes Venture Kick stage 2
We are very pleased to announce that Neurosoft Bioelectronics has passed stage 2 of Venture Kick and received a second round of funding of 40 000 CHF. The Venture Kick jury has selected our project to receive the second “kick” and has chosen to support us in further...
Neurosoft arrives in second position at the >>venture>> 2020 Health & Nutrition competition
During the 2020 >>venture>> award ceremony, Neurosoft Bioelectronics was ranked 2nd in the Health & Nutrition category. We were one of the three finalists (along with Urodea and NextKidney) out of 89 initial applicants in our vertical.The >>venture>> competition...
Neurosoft Bioelectronics selected for MassChallenge Switzerland 2020 Accelerator
Neurosoft Bioelectronics was selected to participate in the MassChallenge Switzerland 2020 accelerator program. We were one of over 1’000 other startups to apply for the accelerator located in Lausanne, Switzerland. This program will allow us to engage with industry...
Neurosoft Bioelectronics receives Catalyze4Life 2020 funding
Neurosoft Bioelectronics is thrilled and proud to announce that it was one of three projects selected for funding through the Catalyze4Life (C4L) competition, organized by EPFL’s School of Life Sciences to identify innovative research projects across EPFL. “The...
Neurosoft is one of the >>venture>> 2020 Health & Nutrition finalists
We are very proud to have been selected as a finalist for the 2020 >>venture>> competition in the Health & Nutrition vertical! >>venture>> is providing us access to a wide network of experts in the Swiss startup scene, and to mentors and...
Neurosoft wins 2020 Swiss Healthcare Startup competition!
We are one of the two startups selected to fly to the Silicon Valley in 2020! The competition started in October 2019 and confronted healthcare companies from all over Switzerland. A jury selected the 10 top startups who were split in two clusters. In the second...